© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Agomelatine, Mixed Polymorph 2, stands out among raw materials for pharmaceuticals thanks to its unique blend of physical properties and structural variety. The polymorphic nature describes different crystal forms found within the same molecule, a phenomenon common in the pharmaceutical world and often closely linked to performance in medications. Agomelatine itself shows potential as an antidepressant because of its distinctive pathway in the human brain. Its polymorphs, including Mixed Polymorph 2, introduce further layers of complexity, sometimes affecting how the drug dissolves, absorbs, or stabilizes in different formulations.
This substance can manifest as flakes, powder, pearls, solid, or even as highly pure crystals. You can spot subtle variations in density, color, and tactile quality depending on conditions during manufacture. Its molecular formula, C15H17NO2, lays the foundation for its biological activity and reactivity in both laboratory and clinical environments. Each physical form influences not just the appearance, but also how the chemical interacts with solvents, excipients, and storage conditions. The various forms — whether in powder for ease of blending, flakes for stability in certain mixtures, or even solutions for fast absorption — allow scientists and formulation experts to fine-tune their products based on real-world demands of shelf-life and performance.
Good chemical stewardship always starts with reliable specifications. Mixed Polymorph 2 stays within its tight molecular bounds, offering a specific density that often hovers around 1.16 g/cm³, though batch variation can tweak this slightly. This number becomes crucial for those measuring out precise amounts for trial batches or industrial production. The compound’s melting point, remarkably consistent across forms, signals the structural cohesion that makes it amenable to further down-the-line synthesis or formulation. Hazardous properties matter here too: like most active raw materials, Agomelatine demands proper handling. Prolonged skin contact sometimes leads to mild irritation, so gloves and lab coats remain standard gear. Inhaling dust should be avoided — common sense echoed in every safety data sheet across the globe. The compound carries no high-profile environmental risks in low dosages but disposal practices require due diligence, especially for larger lots or expired stocks.
Regulatory authorities, customs, and industry databases categorize Agomelatine, Mixed Polymorph 2, under the HS Code 29349990 — a catch-all for miscellaneous organic compounds not elsewhere classified. This code streamlines global movement, making import-export paperwork less of a headache. Looking at the molecular formula, C15H17NO2, those well-versed in chemistry immediately recognize the presence of a core naphthalene ring connected to auxiliary chains, a scaffold popular for its metabolic resilience and target specificity. The presence of both aromatic and aliphatic regions shapes its compatibility with solvents, excipients, and packaging materials. This versatility proves handy in both R&D workbenches and full-scale plants, where switching between raw material forms saves time and reduces waste.
Agomelatine’s property set hinges on its stable crystal lattice, providing protection against humidity and light in most forms. In powder form, its high surface area speeds up dissolution — a necessary feature for those developing fast-acting formulations. The material also exhibits mild hygroscopicity, so airtight containers reduce clumping and ensure product remains easy to measure. Sensitivity to extreme heat leads processors to opt for low-temperature crystal storage or rapid throughput in warmer climates. Its chemical reactivity remains low under neutral pH but picks up in strong acid or alkali environments, which shapes how it gets processed and packaged before reaching patients or researchers.
From experience in mid-sized laboratories to larger manufacturing setups, the bane of many production runs can stem from improper material storage. Mixed Polymorph 2 resists degradation under ordinary light, yet retains best potency when sealed from the open air and stored between 15–25°C. Dehydration or excess moisture both knock its processability off-kilter, so environment control keeps batch after batch consistent. For those working with liquid or solution forms, both water and common organic solvents like ethanol or methanol dissolve Agomelatine readily, with clear guidelines on minimum concentrations for stability. Mishandling, such as storing near oxidizing agents or acids, results in unwanted byproducts. Steady focus on clean, dry, and cool storage, with routine inspection, prevents costly losses and maintains compliance with regulatory standards.
No chemical escapes the conversation about safe use and hazards. Even though Agomelatine rarely excites major alarm bells, diligence shapes best practices. Avoiding powder inhalation or eye contact remains a baseline measure. Those filling capsules or vials tend to invest in well-ventilated rooms and low-dust filling techniques. Employees keep material safety data sheets on hand and train newcomers frequently, reinforcing the culture of caution. Small spills or airborne dust often prompt immediate clean-up using filtered vacuums or wet cloths instead of dry sweeping, which prevents wider spread of residue. For those in facilities without advanced waste treatment, engaging licensed hazardous waste handlers for unused stocks protects both community and environment.
Years spent in both the chemical and pharmaceutical sector bring perspective: the details around material form, quality, and handling aren’t academic checklists; they’re the foundation of robust supply chains and safe patient outcomes. Every specification, every batch release note, carries a weight shaped by both science and hands-on experience. Teams who treat each container of Agomelatine, Mixed Polymorph 2, as more than just another commodity build reputations for reliability and responsibility. Trust earned this way doesn’t simply meet audit requirements but supports researchers, formulators, and end-users alike — making sure that from molecular structure right through to package label, the story adds up.
